These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563 [TBL] [Abstract][Full Text] [Related]
4. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138 [TBL] [Abstract][Full Text] [Related]
5. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142 [TBL] [Abstract][Full Text] [Related]
8. Role of Dual-Hormone Closed-Loop Delivery System in the Future. Bally L; Thabit H; Hovorka R Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812 [No Abstract] [Full Text] [Related]
9. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393 [TBL] [Abstract][Full Text] [Related]
11. Frequency and Detection of Insulin Infusion Site Failure in the Type 1 Diabetes Exchange Online Community. Hughes MS; Douvas JL; Layfield-Bryan M; Blanco LE; Gray JC; Zapotoczny G; Espinoza J; Wilcox JH; Lal RA Diabetes Technol Ther; 2023 Jun; 25(6):426-430. PubMed ID: 36856574 [TBL] [Abstract][Full Text] [Related]
12. Advances in Insulin Infusion Set in the New Era of Automated Insulin Delivery: A Systematic Review. Zhang G; Romo-Anselmo E; Kwa T; Cohen O; Vigersky R; Chattaraj S J Diabetes Sci Technol; 2023 Mar; 17(2):302-313. PubMed ID: 36562593 [TBL] [Abstract][Full Text] [Related]
13. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. Heinemann L; Krinelke L J Diabetes Sci Technol; 2012 Jul; 6(4):954-64. PubMed ID: 22920824 [TBL] [Abstract][Full Text] [Related]
15. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related]
16. Management of the hospitalized diabetes patient with an insulin pump. McCrea D Crit Care Nurs Clin North Am; 2013 Mar; 25(1):111-21. PubMed ID: 23410650 [TBL] [Abstract][Full Text] [Related]